Drug Discovery Science Products and Equipment | Technology Networks

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Featured Products

Seahorse XF MitoTox Assay Kit, mitochondrial toxicity, drug discovery, toxicity assessment, toxicology research, drug safety

Seahorse XF MitoTox Assay Kit for Mitochondrial Toxicity and Drug Safety Evaluation

SYNTHIA™ Retrosynthesis Software

SYNTHIA™ Retrosynthesis Software

SCIEX Echo(R) MS system: Accelerating drug discovery with acoustic ejection mass spectrometry

SCIEX Echo(R) MS system: Accelerating drug discovery with acoustic ejection mass spectrometry

Don't Gamble With Your Research: The Winning Hand of Label-Free Protein Characterization

Build Your Own Panel of Up to 21 Human Protein Biomarkers From a Pre-Validated Library of ∼ 200 Assays Covering Major Disease Areas

LED Photoreactor for Glass Static Mixer Blocks

Latest Products

A worker in a lab.

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria

Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.

A scientist behind a screen.

Armis Biopharma Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds

Armis Biopharma, Inc. announced that the company received a $20.3 million contract from the Defense Threat Reduction Agency (DTRA) to develop its proprietary Veriox® DECON chemical warfare agent (CWA) decontamination product.

A frozen Eppendorf tube held with tweezers.

Modelling Enables Breakthroughs in Neuromuscular Disease Research

A team of scientists have developed a protocol for the fabrication of a 3D microfluidic neuromuscular platform that can be used to model Motor Neuron Diseases (MND’s).

An outsretched palm holding an assortment of different pills.

PharmaKure Submits Mhra CTA for Phase 2a Clinical Trial of PK051 in Patients With Mild Cognitive Impairment

Clinical Trial Application filed for combined drug targeting amyloid deposits associated with Alzheimer’s Disease.

An individual sitting at a table with their laptop open.

Optibrium Introduces Cloud-Based Version of StarDrop Drug Discovery Platform

Optibrium, announced that its drug discovery platform, StarDrop, is now also available in the cloud environment.

A scientist pipetting into an Eppendorf tube.

New Mid-Term Guidance 2024 – 2028 Supported by Ramp-Up of Growth Projects

At its Capital Markets Day in Visp (CH), Lonza shared a detailed update on its strategic priorities and provided new Mid-Term Guidance for 2024 to 2028.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter